Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

Phase 1b study to evaluate MK 0482 for Relapsed/Refractory AML/CMML Ended

2023-503580-42-00 Active CNS leukemia. 2023-05-16
A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of OMS90… Ended

2022-501190-39-01 Paroxysmal nocturnal hemoglobinuria 2023-05-15
MK-7602 Multiple Ascending Dose Study in Healthy Participants Ended

2023-503738-36-00 Malaria 2023-05-12
Transcranial Magnetic Stimulation (TMS) Evaluation of Central Nervous System (CNS) Pharmacodynamic (PD) Activity of Brexanolone in Healthy M… Ended

2022-503019-40-00 NA, PD study in Healthy Volunteers 2023-05-11
Safety, tolerability and pharmacokinetics of intra‐articular (IA) single ascending dose of 4P‐004 in patient with Kellgren and Lawrence grad… Ended

2022-500271-31-00 Knee osteoarthritis 2023-05-10
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics)… Ended

2022-502951-77-00 Healthy Adult Participants 2023-05-05
A study in healthy men to test how BI 764198 is processed in the body Ended

2022-502327-22-00 Healthy 2023-05-03
Pilot trial of single dose ilofotase alfa in hypophosphatasia Ended

2023-503186-35-00 Hypophosphatasia 2023-05-03
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended

2022-502872-22-00 Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcera 2023-04-28
Tramadol Administered Orally to Healthy Subjects for the Improvement of its Detection in Biological Matrices in the Context of Anti-Doping … Ended

2023-503799-25-00 healthy subjects 2023-04-27
A study in healthy men to test how BI 1291583 is processed in the body Ended

2022-502264-20-00 Healthy 2023-04-26
A study to compare how different substances (caffeine, warfarin, omeprazole, metoprolol, and midazolam) are handled by the body of healthy p… Ended

2024-514622-22-00 1. Patients with compensated liver cirrhosis due to any 2023-04-25
A Phase I Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA0-Tyr3-Octreotate in Children … Ended

2024-515552-21-00 Recurrent or refractory neuroblastoma. 2023-04-17
Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s Disease Ended

2023-503203-29-00 Parkinson's Disease 2023-04-12
Albendazole pharmacokinetics in plasma, intra-cystic fluid and cystic tissue of human cystic and alveolar echinococcosis Ended

2024-518548-19-00 Human echinococcosis 2023-03-27
Phase 1b study investigating the association of NP137 with mFOLFIRINOX in locally advanced pancreatic ductal adenocarcinoma LAP NET 1 Ended

2022-500905-42-00 pancreatic ductal adenocarcinoma 2023-03-24
A Phase 1b Trial of ARV-471 in Combination with Everolimus in Patients with ER+, HER2– Advanced or Metastatic Breast Cancer Ended

2024-513284-30-00 ER+, HER2– Advanced or Metastatic Breast Cancer 2023-03-22
Evaluation of the value of 18F-Fluoromisonidazole (18F-FMISO) positron emission tomography hypoxia imaging in idiopathic pulmonary fibrosis … Ended

2024-515303-19-00 idiopathic pulmonary fibrosis 2023-03-20
A Phase 1 Study of the SHP2 Inhibitor BBP-398 (formerly known as IACS-15509) in combination with the KRAS-G12C Inhibitor Sotorasib in Patien… Ended

2022-501363-40-00 Advanced or metastatic solid tumors with a KRAS-G12C mu 2023-03-17
Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after… Ended

2024-510980-40-00 Small cell lung cancer 2023-03-09
Safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous and subcutaneous multiple rising doses of BI 765250 versus place… Ended

2024-512420-10-00 Plaque psoriasis 2023-03-09
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers. Proof of concept. Ended

2022-502216-36-00 Healthy volunteers 2023-02-27
A Randomized, Double-Blind (Sponsor-Unblinded), Placebo-Controlled, Single And Multiple Ascending Dose Study To Evaluate Safety, Tolerabilit… Ended

2024-512987-74-00 Disorders characterized by a deficit in GABAergic signa 2023-02-27
A study investigating the safety, tolerability, absorption, excretion and effects of a new drug for the treatment of epilepsy. Ended

2022-502638-17-00 Epilepsy 2023-02-03